🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A retrospective study of de-identified (to preserve patient privacy) patien...
Status
Completed
Location
Pfizer New York
Start Date
2023-09-29
Trial ID
NCT06086340
Treatments Being Tested
The purpose of this study is to describe the effect of the medicine palboci...
Status
Completed
Location
Copenhagen University Hospital, Rigshospitalet
Start Date
2024-03-06
Trial ID
NCT06307457
Treatments Being Tested
This ComboMATCH patient screening trial is the gateway to a coordinated set...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-04-07
Trial ID
NCT05564377
Treatments Being Tested
The study is designed to describe patient characteristics, treatment patter...
Status
Completed
Location
Syapse
Start Date
2020-06-30
Trial ID
NCT04394247
The primary objective of Phase 1b will be to evaluate the safety and tolera...
Status
Terminated
Location
Holy Cross Health Fort Lauderdale - Holy Cross Hospital
Start Date
2023-01-09
Trial ID
NCT05384119
Treatments Being Tested
The aim of the present study is to evaluate the efficacy and safety of palb...
Status
Unknown
Location
Nuovo ospedale di Prato - S. Stefano
Start Date
2019-07-16
Trial ID
NCT04318223
Treatments Being Tested
The purpose of this study is to generate evidence on an alternative dosing ...
Status
Recruiting
Location
Ironwood Cancer & Research Centers
Start Date
2024-10-29
Trial ID
NCT06377852
Treatments Being Tested
The goal of this clinical trial is to assess the efficacy, safety and toler...
Status
Recruiting
Location
Mayo Clinic - Scottsdale
Start Date
2023-10-31
Trial ID
NCT05696626
Treatments Being Tested
Palbociclib, the first oral CDK4/6 inhibitor, is an approved medicine indic...
Status
Active Not Recruiting
Location
Pfizer New York
Start Date
2024-06-24
Trial ID
NCT06495164
Treatments Being Tested
This study is a randomized, open-label, multicentric, phase III trial condu...
Status
Completed
Location
Centre Hospitalier Universitaire
Start Date
2017-03-22
Trial ID
NCT03079011
Treatments Being Tested